Back
Invesco FTSE RAFI Dev Mkts ex-US ETF Vs. Cytokinetics Industry Stock Comparison
Sell
40
PXF
Invesco FTSE RAFI Dev Mkts ex-US ETF
Last Price:
48.89
Seasonality Move:
0.55%
Buy
52
CYTK
Cytokinetics
Last Price:
52.86
Seasonality Move:
5.69%
Sell
40
Invesco FTSE RAFI Dev Mkts ex-US ETF (PXF)
is a Sell
Is Invesco FTSE RAFI Dev Mkts ex-US ETF a Buy, Sell or Hold?
- The current Invesco FTSE RAFI Dev Mkts ex-US ETF [PXF] share price is $48.80. The Score for PXF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PXF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Cytokinetics (CYTK)
is a Buy
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $53.85. The Score for CYTK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PXF Stock Price Chart
What is Invesco FTSE RAFI Dev Mkts ex-US ETF's stock price today?
-
The Invesco FTSE RAFI Dev Mkts ex-US ETF share price today is $48.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PXF is experiencing slight selling pressure.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $53.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.
PXF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 38.74 | Sell |
| Chaikin Money Flow: | -66870 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.31 - 50.87) | Sell |
| Bollinger Bands (100): | (47.73 - 50.25) | Sell |
CYTK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.4 | Sell |
| Relative Strength Index (14 RSI): | 47.99 | Sell |
| Chaikin Money Flow: | 69998 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.06 - 56.58) | Buy |
| Bollinger Bands (100): | (56.38 - 74.98) | Sell |
PXF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.13 | Sell |
| 20-day SMA: | 49.92 | Sell |
| 50-day SMA: | 49.66 | Sell |
| 200-day SMA: | 46.94 | Buy |
| 8-day EMA: | 49.18 | Sell |
| 20-day EMA: | 49.64 | Sell |
| 50-day EMA: | 49.61 | Sell |
| 200-day EMA: | 47.62 | Buy |
CYTK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.08 | Buy |
| 20-day SMA: | 51.6 | Buy |
| 50-day SMA: | 58.73 | Sell |
| 200-day SMA: | 55.73 | Sell |
| 8-day EMA: | 53.02 | Buy |
| 20-day EMA: | 53.6 | Buy |
| 50-day EMA: | 57.71 | Sell |
| 200-day EMA: | 56.9 | Sell |
Invesco FTSE RAFI Dev Mkts ex-US ETF Earnings Growth & PXF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.08 per share.
Invesco FTSE RAFI Dev Mkts ex-US ETF Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cytokinetics Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||